Home > Healthcare & Medical Devices > Biopsy Devices Market

Biopsy Devices Market Size By Product (Biopsy Guidance Systems [Manual, Robotic], Needle Based Biopsy Guns [Vacuum-Assisted, Fine Needle, Core Needle] Biopsy Needles [Disposable, Reusable], Biopsy Forceps [General Biopsy, Hot Biopsy], Others [Brushes, Curettes, Punches)], By End-use (Hospitals, Ambulatory Surgical Centers), COVID-19 Impact Analysis, Regional Outlook, Application Potential, Competitive Market Share & Forecast, 2021 - 2027

  • Report ID: GMI731
  • Published Date: Jun 2021
  • Report Format: PDF

Industry Trends

Biopsy Devices Market size exceeded USD 1.5 billion in 2020 and is expected to grow at a CAGR of over 8.5% through 2027. Biopsy devices are used to remove a piece of a sample or a tissue of cells from the body to analyse in the laboratory for presence of a disease. Increasing incidence of cancer and rising prevalence of various infectious diseases are escalating the demand for biopsy devices.

Biopsy Devices Market Overview

Get more details on this report - Request Free Sample PDF

Rising awareness about breast cancer diagnosis and treatment will stimulate the market statistics. Moreover, favourable reimbursement policies coupled with increasing health expenditure are also the factors driving the overall market expansion. According to the American Cancer Society (ACS), the total U.S. healthcare spending on cancer in 2020 was approximately USD 200 billion and is projected to reach USD 245 billion by 2030. Thus, increasing cancer treatment and diagnosis costs coupled with a growing number of cancer cases will fuel the biopsy devices market forecasts.

Technological advancements in biopsy devices will influence the market outlook

Technological advances in biopsy devices are leading to the increasing adoption of minimally invasive procedures. The significant development in imaging technology such as CT, ultrasound, and MRI are enabling healthcare providers to make detection with greater assurance. Thus, based on the current trend, the relative percentage of biopsies done using imaging technologies will continue to rise during the forecast period.

Increasing use of smart biopsy devices in various applications of healthcare are the factors fuelling the overall market share. These smart biopsies have the potential to be used in treatment modalities also. The high cost of invasive biopsies and the associated pain involved in surgical procedure leads to a significant rise in the acceptance of smart biopsy devices. Thus, factors such as real-time cancer tissue characterization and the low cost of smart biopsy devices will boost the industry statistics during the forecast timeline.

Innovations in biopsy guided system are augmenting the biopsy devices market demand

Biopsy Devices Market Revenue

Get more details on this report - Request Free Sample PDF

Biopsy guidance systems segment held more than 39% revenue share of global market in 2020. Image-guided biopsies are used when the tumour is deep inside the body. Biopsy guidance systems offer high-quality images of small tissues and are also cost-effective. These guided biopsies can provide continuous real-time visualizations that increase patient comfort and speed. Furthermore, guided biopsies can allow rapid sampling of multiple lesions and access to axillary and subareolar regions.

Increasing demand for robotic biopsies owing to a less invasive nature is the factor impelling the segment growth. Additionally, a rising number of product launches coupled with speedy FDA approval is also contributing to the segment expansion.

Increasing patient inflow accessing cancer disease treatment in hospitals will simulate the market statistics

Significant increase in the hospital stay due to cancer is the major contributing factor for the segment expansion. Presence of sophisticated facilities and equipment for timely diagnosis and treatment further attracts larger patient pool. Thus, growing patient population coupled with advanced diagnostic tools in hospitals will enhance the overall biopsy devices market outlook.

Presence of leading industry players catering to growing product demand will continue to strengthen the North American industry projection

North America biopsy devices market captured over 54% of revenue share in 2020. Greater regional share is primarily credited to the presence of a large patient pool and numerous industry leaders operating in the U.S. Additionally, rising incidence of cancer coupled with continuous technological advancements is driving the regional market size. Thus, an advanced healthcare system coupled with a high penetration rate of technologically advanced devices will propel the regional industry landscape.

Product launch and collaborations to broaden accessibility assist the companies in their business expansion

Global biopsy devices market is dominated by companies such as Argon Medical Devices, Inc., Becton and Dickinson and Company, B. Braun Melsungen AG, Hologic, Inc. and others. These participants are implementing various strategic initiatives and technological collaborations to stay competitive in the market.

Some of the recent industry developments:

  • In March 2021, Izi Medical Product launched fully automated Quick-Core-Auto Biopsy System. This will boost company’s product portfolio and market presence.

The biopsy devices market research report includes an in-depth coverage of the industry with estimates & forecast in terms of revenue in USD from 2016 to 2027 for the following segments:

By Products

  • Biopsy Guidance System
    • Manual
    • Robotic
  • Needle Based Biopsy Guns
    • Vacuum-assisted Biopsy (VAB) Devices
    • Fine Needle Aspiration Biopsy (FNAB) Devices
    • Core Needle Biopsy (CNB) Devices
  • Biopsy needles
    • Disposable
    • Reusable
  • Biopsy forceps
    • General Biopsy Forceps
    • Hot Biopsy Forceps
  • Others
    • Brushes
    • Curettes
    • Punches

By End-use

  • Hospitals
  • Ambulatory Surgical Centers
  • Others

The above information is provided for the following regions and countries:

  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • UK
    • France
    • Spain
    • Italy
  • Asia Pacific
    • China
    • Japan
    • India
  • Latin America
    • Brazil
    • Mexico
    • Argentina
  • Middle East & Africa
    • Saudi Arabia
    • South Africa


Authors: Sumant Ugalmugle, Rupali Swain

Frequently Asked Questions (FAQ) :

Biopsy devices market size had reached USD 1.5 billion in 2020 and will record a CAGR of over 8.5% through 2027.

Biopsy guidance systems segment had accounted for over 39% market share in 2020 as it offers high-quality images of small tissues and is also cost-effective.

North America biopsy devices market had held over 54% of revenue share in 2020 on account of the presence of large patient pool and various industry players in the region.

Increased patient admissions due to cancer and availability of sophisticated facilities for timely diagnosis and treatment are the major factors impelling the product demand in hospitals.

Buy Now

Access to only 1 person; cannot be shared; cannot be printed
Access for 2 to 5 users only within same department of one company
Access to a company wide audience; includes subsidiary companies or other companies within a group of companies
Immediate Delivery Available

Premium Report Details

  • Base Year: 2020
  • Companies covered: 13
  • Tables & Figures: 191
  • Countries covered: 15
  • Pages: 339

Get a report that explains COVID-19 impact on this market

 Request Free Sample

Budget constraints? Get in touch with us for special pricing

Request Discount